Farms.com Home   News

Food waste is just wrong

Dear Editor:
 
Why is the discussion of regenerative land practices not a priority around British Columbia as it is in many other agricultural areas?
 
I see some organic farmers using these practices here, but not enough.
 
Non-industry funded science is showing that biodiversity in living ecosystems prevents severe pest damage better than the industrial chemical or GMO (genetically modified organism) approaches.
 
Living soil in a living ecosystem will balance out the damage done to human crops, this is shown by science.
 
It’s time we started mimicking nature rather than fighting it (as the industry promotes, as it feeds their sales).
 
Part of the problem is the food waste encouraged by the commercial insistence on perfect products, as if nature were a factory production line.
 
I eat apples even if there is an imperfection, I don’t see why we can’t have a seconds bin for those of us happy to eat imperfect food rather than throwing it all in the garbage.
 
Food waste for aesthetics is just wrong when people go hungry.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.